ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,746Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 51

$538K Total Retail Price of All Prescriptions

Rank: 3 out of 51

310 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in District of Columbia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 310 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

10% of this provider’s 310 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 6,778 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $73 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in District of Columbia
FUROSEMIDE 457 343 1 4
AMLODIPINE BESYLATE 386 304 2 2
METOPROLOL SUCCINATE 324 231 3 3
METFORMIN HCL 269 183 4 10
LISINOPRIL 237 158 5 1
SIMVASTATIN 222 193 6 6
ATORVASTATIN CALCIUM 197 147 7 5
CLOPIDOGREL 171 160 8 13
DIOVAN 162 110 9 16
IBUPROFEN 135 92 10 32
DIOVAN HCT 133 117 11 25
PLAVIX 130 123 12 15
OXYCODONE-ACETAMINOPHEN 130 78 S2 12 31
LEVOTHYROXINE SODIUM 118 117 14 35
AZITHROMYCIN 114 85 15 48
METOPROLOL TARTRATE 111 105 16 9
NAMENDA 109 109 17 65
CARVEDILOL 108 84 18 7
FLUTICASONE PROPIONATE 105 78 19 67
HYDROCHLOROTHIAZIDE 104 72 20 8
ACETAMINOPHEN-CODEINE 97 72 S3 21 19
ZOLPIDEM TARTRATE 91 70 22 34
KLOR-CON 10 90 85 23 71
CLONIDINE HCL 90 61 23 26
PROAIR HFA 87 46 25 46
HYDRALAZINE HCL 86 67 26 17
POTASSIUM CHLORIDE 82 76 27 37
EXFORGE 81 66 28 73
GLIPIZIDE 76 42 29 38
ADVAIR DISKUS 76 46 29 49
KLOR-CON M10 75 64 31 53
CRESTOR 71 65 32 12
CYCLOBENZAPRINE HCL 70 23 R 33 52
LOSARTAN POTASSIUM 69 69 34 11
ATENOLOL 65 53 35 26
SPIRONOLACTONE 63 24 36 20
NIFEDIPINE ER 63 40 36 21
CIPROFLOXACIN HCL 62 51 38 81
ALLOPURINOL 62 58 38 62
OMEPRAZOLE 62 36 38 22
WARFARIN SODIUM 61 38 41 14
TAMSULOSIN HCL 59 49 42 54
DIGOXIN 55 44 43 23
NAPROXEN 55 50 43 49
PANTOPRAZOLE SODIUM 54 43 45 60
GABAPENTIN 54 44 45 40
LIPITOR 50 44 47 41
GLYBURIDE 50 26 R 47 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.